Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
48 hedge funds and large institutions have $146M invested in Marrone Bio Innovations, Inc. in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 2 closing their positions.
420% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 5
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
51% more capital invested
Capital invested by funds: $96.8M → $146M (+$49.4M)
20% more funds holding
Funds holding: 40 → 48 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$31.9M |
| 2 |
Primecap Management
Pasadena,
California
|
+$17.3M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$11.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.98M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$3.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$5.01M |
| 2 |
EEG
E.E. Geduld
|
-$78.5K |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
-$33K |
| 4 |
Citigroup
New York
|
-$16.1K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$15.7K |
MBII Hedge Fund Activity: Q1 2014 in Review
48 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2014, worth a combined $146M — up 51% from $96.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MBII positions and 2 closed out — a net gain of 8 holders — while 26 added to existing stakes and 5 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $31.9M. The largest seller was Massachusetts Financial Services, cutting an estimated $5.01M.
- 48 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2014, up from 40 in Q4 2013.
- Funds reported $146M of Marrone Bio Innovations, Inc. stock for Q1 2014, up 51% quarter-over-quarter.
- 10 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2014 and 2 closed out, a net change of +8 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2014 was Gilder Gagnon Howe & Co, an estimated $31.9M added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2014 was Massachusetts Financial Services, an estimated $5.01M sold.
Based on aggregated 13F filings for Q1 2014.